EE+ POEM Archive
SGLT2 inhibitors optimal drug class for heart failure with preserved and mildly reduced ejection fraction
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "SGLT2 Inhibitors Optimal Drug Class for Heart Failure With Preserved and Mildly Reduced Ejection Fraction." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315724/all/SGLT2_inhibitors_optimal_drug_class_for_heart_failure_with_preserved_and_mildly_reduced_ejection_fraction.
SGLT2 inhibitors optimal drug class for heart failure with preserved and mildly reduced ejection fraction. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315724/all/SGLT2_inhibitors_optimal_drug_class_for_heart_failure_with_preserved_and_mildly_reduced_ejection_fraction. Accessed May 13, 2024.
SGLT2 inhibitors optimal drug class for heart failure with preserved and mildly reduced ejection fraction. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315724/all/SGLT2_inhibitors_optimal_drug_class_for_heart_failure_with_preserved_and_mildly_reduced_ejection_fraction
SGLT2 Inhibitors Optimal Drug Class for Heart Failure With Preserved and Mildly Reduced Ejection Fraction [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 May 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315724/all/SGLT2_inhibitors_optimal_drug_class_for_heart_failure_with_preserved_and_mildly_reduced_ejection_fraction.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - SGLT2 inhibitors optimal drug class for heart failure with preserved and mildly reduced ejection fraction
ID - 1315724
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315724/all/SGLT2_inhibitors_optimal_drug_class_for_heart_failure_with_preserved_and_mildly_reduced_ejection_fraction
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
